Join the Empagliflozin group to help and get support from people like you.
Empagliflozin News (Page 2)
FDA Medwatch Alert: SGLT2 inhibitors: Drug Safety Communication - FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood
ISSUE: FDA is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of blood...
FDA Approves Glyxambi (empagliflozin and linagliptin) for Type 2 Diabetes
RIDGEFIELD, Conn. and INDIANAPOLIS, Feb. 2, 2015 – The U.S. Food and Drug Administration (FDA) has approved Glyxambi (empagliflozin/linagliptin) tablets, from Boehringer Ingelheim Pharmaceuticals, I...
Further information
Related condition support groups
Chronic Kidney Disease, Heart Failure, Congestive Heart Failure, Cardiovascular Risk Reduction, Diabetes, Type 2